Intrinsic Value of S&P & Nasdaq Contact Us

RxSight, Inc. RXST NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.00
+51.3%

Stock Statistics — RXST

RxSight, Inc. (RXST) has a market capitalization of $300.01M and trades at $7.27. The 52-week range is 5.9-17.52.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -7.7, Earnings Per Share (EPS) of $-0.95, annual revenue of $134.48M.

The stock has a beta of 1.21, operates in the Healthcare sector.

Trading Data
Current Price$7.27
52-Week Range5.9-17.52
Volume501.32K
Avg Volume (30D)897.81K
Market Cap$300.01M
Beta (1Y)1.21
Company
IPO Date2021-07-30
Employees498
CEORonald Kurtz
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS78349D1072
CUSIP78349D107
Income (Latest Year)
Revenue$134.48M
Gross Profit$103.01M
EBITDA$-39.62M
Operating Income$-48.19M
Net Income$-38.94M
EPS$-0.95
EPS Diluted$-0.95
Shares Outstanding$41.18M
Balance Sheet (Latest Year)
Total Assets$311.81M
Current Assets$287.46M
Cash & ST Investments$228.13M
Total Liabilities$36.13M
Total Debt$11.04M
Net Debt$-8.91M
Total Equity$275.68M
Debt / Equity0.04
Valuation Ratios
P/E Ratio-7.7
P/S Ratio2.23
P/B Ratio1.09
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message